ARCHIVES

FDA Simplifies Reporting Of Adverse Events

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

NCI to Study Review Group’s report Urging Restructure of Prevention Programm

June 27, 1997

Monroe Wall, Co-Discoverer Of Taxol, Camptothecin, Dead At 85

July 12, 2002

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

Prostate Cancer Prevention Trial Begins At 222 U.S. Sites

October 22, 1993

NCI-Approved CTEP Trials For the Month of October

October 26, 2012

NCI, ACS, Health Departments Launch ASSIST, Goal To Cut US Smoking Rate In Half By Yr 2000

October 11, 1991